Market Research Logo

Conference Documentation: Asthma & COPD

Conference Documentation: Asthma & COPD

SMi is proud to announce the return the 12th annual Asthma & COPD conference 2016 in London!

Respiratory diseases represent an enormous and increasing healthcare and economic burden across Europe and USA.
Over the last few years, significant improvements in the management of asthma and COPD have been made, owing to new drugs, strategies and to the development of the nonpharmacologic treatment of COPD. Nevertheless, there are still many unmet needs in the treatment of these diseases.

Join us at SMi's 12th annual Asthma & COPD taking place on the 11th - 12th April 2016 in London. This event will explore innovative asthma and COPD drug development programmes, directives and procedures which have been put in place to reduce the enormous suffering from lung disease and its high mortality.

A series of practical case studies, interactive roundtables and panel discussion facilitated by leading industry experts will provide executives with useful tools and best practices to:
develop vaccination approaches for asthma
improve inhaled therapies in COPD and development of antivirals
evaluate the impact of COPD phenotypes on therapy
explore biomarkers for respiratory drug assessment
learn about stratified medicine and prevent exacerbation in asthma and COPD

and many more...


Day 1
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Ewan Walters, Medical Director, Teva UK Ltd
9:10
Recent advances in asthma and COPD management
Neil C Thomson, Professor of Respiratory Medicine, University of Glasgow
9:50
COPD: Unmet Need and Challenges in NHS Care
John Hurst, Senior Clinical Lecturer, Honorary Consultant, University College London
10:30
Morning Coffee
11:00
Developing and registering new inhalers to deliver clinical benefits in asthma
Ewan Walters, Medical Director, Teva UK Ltd
11:40
Development challenges for Generic Inhalation Products for EU and US markets
Nayna Govind, Director for the development of generic inhalation products , Dr Reddys Laboratories
12:20
Networking Lunch
13:30
Formulation and process challenges in the development of inhaled products
Frank Thielmann, Operational Lead, Inhalation New Solids, Novartis Pharma AG
14:10
RPL554, a novel first-in-class inhaled drug for the treatment of exacerbations of chronic obstructive pulmonary disease (COPD), and cystic fibrosis
Jan-Anders Karlsson, CEO , Verona Pharma
14:50
Afternoon Tea
15:20
Recent advances in drug development & treatment of asthma and COPD
Beverley Patterson, Inhalation Clinical Associate Director, Actavis
16:00
Innate Lymphocytes (ILC) in COPD
Roland Kolbeck, Senior Director, MedImmune
16:40
Chairman’s Closing Remarks and Close of Day One
Day 2
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Peter Daley Yates, Director Clinical Pharmacology, GSK
9:10
Design implications and challenges in developing treatments for idiopathic pulmonary fibrosis
Andy Kenwright, Project Statistician , Roche Products Limited
9:50
Is global harmonisation of OIP requirements possible?
Michelle Lee-Bourner, Head of regulatory, Mylan Pharma UK
10:30
Morning Coffee
11:00
Corticosteroid insensitivity in severe asthma: mechanisms and new targets
Pankaj Bhavsar, Research Lecturer, Imperial College London
11:40
Clinical development of
generic DPls
Katerina Athanassiou, CR Director, ELPEN Pharmaceutical Co. Inc
12:20
Networking Lunch
13:30
Improving inhealed therapies
Peter Daley Yates, Director Clinical Pharmacology, GSK
14:10
Performance Characterisation of Inhalation Products
Jan Olof Svensson, Principle Scientist AstraZeneca R&D, AstraZeneca
14:50
Afternoon Tea
15:20
Scientific aspects of quality regulations in respiratory drug development
Stefan Leiner, Chemical-Pharmaceutical Expert, Boehringer Ingelheim
16:00
Challenges of developping drug-device combination products
Mark Chipperfield, Director & Principal Consultant, Corvus Device Limited
16:40
Chairman’s Closing Remarks and Close of Day Two

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report